Pacira Biosciences, Inc. (PCRX)
22.70
-0.09
(-0.39%)
USD |
NASDAQ |
Apr 02, 16:00
22.69
-0.01
(-0.04%)
After-Hours: 20:00
Pacira Biosciences Shareholders Equity (Quarterly) : 693.11M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 274.24M |
| Stryker Corp. | 22.42B |
| CorMedix, Inc. | 405.31M |
| Krystal Biotech, Inc. | 1.220B |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.265B |
| Total Liabilities (Quarterly) | 571.81M |
| Debt to Equity Ratio | 0.6034 |
| Current Ratio | 4.544 |
| Net Debt Paydown Yield | 4.25% |